Ameritas Investment Partners’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-13,569
| Closed | -$1.08M | – | 3347 |
|
|
2021
Q1 | $1.08M | Hold |
13,569
| – | – | 0.04% | 570 |
|
|
2020
Q4 | $1.07M | Sell |
13,569
-495
| -4% | -$29K | 0.05% | 513 |
|
|
2020
Q3 | $618K | Hold |
14,064
| – | – | 0.03% | 647 |
|
|
2020
Q2 | $622K | Buy |
14,064
+3,676
| +35% | +$137K | 0.03% | 645 |
|
|
2020
Q1 | $373K | Hold |
10,388
| – | – | 0.02% | 712 |
|
|
2019
Q4 | $737K | Hold |
10,388
| – | – | 0.03% | 644 |
|
|
2019
Q3 | $777K | Sell |
10,388
-347
| -3% | -$29.4K | 0.04% | 602 |
|
|
2019
Q2 | $866K | Hold |
10,735
| – | – | 0.04% | 569 |
|
|
2019
Q1 | $718K | Hold |
10,735
| – | – | 0.03% | 635 |
|
|
2018
Q4 | $799K | Hold |
10,735
| – | – | 0.04% | 542 |
|
|
2018
Q3 | $988K | Buy |
10,735
+160
| +2% | +$15.2K | 0.05% | 542 |
|
|
2018
Q2 | $1.04M | Sell |
10,575
-3,094
| -23% | -$346K | 0.05% | 518 |
|
|
2018
Q1 | $1.52M | Buy |
13,669
+10,575
| +342% | +$1.19M | 0.07% | 342 |
|
|
2017
Q4 | $318K | Hold |
3,094
| – | – | 0.01% | 866 |
|
|
2017
Q3 | $251K | Hold |
3,094
| – | – | 0.01% | 942 |
|
|
2017
Q2 | $241K | Hold |
3,094
| – | – | 0.01% | 964 |
|
|
2017
Q1 | $248K | Hold |
3,094
| – | – | 0.01% | 952 |
|
|
2016
Q4 | $244K | Hold |
3,094
| – | – | 0.01% | 942 |
|
|
2016
Q3 | $241K | Buy |
+3,094
| New | +$224K | 0.01% | 941 |
|
Ameritas Investment Partners's CMD Position: Q2 2021 in Review
Ameritas Investment Partners sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 13,569 shares — an estimated $1.08M sold.
Ameritas Investment Partners first reported a position in CMD in Q3 2016 and held it in 19 quarters. The position peaked at $1.52M in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Ameritas Investment Partners reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Ameritas Investment Partners sold 13,569 Cantel Medical Corporation shares in Q2 2021, an estimated $1.08M.
- Ameritas Investment Partners first reported a position in Cantel Medical Corporation in Q3 2016 and held it in 19 quarters.
- Ameritas Investment Partners's Cantel Medical Corporation position peaked at $1.52M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.